Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vascular decomposition using weighted approximate convex decomposition.
Chowriappa A, Kesavadas T, Mokin M, Kan P, Salunke S, Natarajan SK, Scott PD. Chowriappa A, et al. Among authors: salunke s. Int J Comput Assist Radiol Surg. 2013 Mar;8(2):207-19. doi: 10.1007/s11548-012-0766-6. Epub 2012 Jun 13. Int J Comput Assist Radiol Surg. 2013. PMID: 22696198
3-D vascular skeleton extraction and decomposition.
Chowriappa A, Seo Y, Salunke S, Mokin M, Kan P, Scott P. Chowriappa A, et al. Among authors: salunke s. IEEE J Biomed Health Inform. 2014 Jan;18(1):139-47. doi: 10.1109/JBHI.2013.2261998. IEEE J Biomed Health Inform. 2014. PMID: 24403411
Myositis India: Early lessons from a patient support group in a resource-limited setting.
Aggarwal A, Bagri NK, Kavadichanda C, Upadhyaya S, Haldule S, Ladha P, Jain N, Pathak H, Das P, Mittal S, Tope RA, Nikale AA, Nimal S, Mehta P, Chandwar K, Dudam R, Malviya S, Rao VKR, Singh S, Sharma V, Edpuganti N, Nalkande R, Salunke S, Madan U, Batra V, Aggarwal R. Aggarwal A, et al. Among authors: salunke s. Int J Rheum Dis. 2024 Sep;27(9):e15351. doi: 10.1111/1756-185X.15351. Int J Rheum Dis. 2024. PMID: 39304342 No abstract available.
Paediatric excipient risk assessment (PERA) tool and application for selecting appropriate excipients for paediatric dosage forms - Part 2.
Agrawal A, Salunke S, Rumondor A, Thompson K, Caivano G, Walsh J, Enright B, Sherratt P, Hughes K, Clapham D, Kuehl P; International Consortium (IQ) for Innovation and Quality in Pharmaceutical Development and European Paediatric Formulation Initiative (EuPFI). Agrawal A, et al. Among authors: salunke s. Eur J Pharm Biopharm. 2024 Oct;203:114447. doi: 10.1016/j.ejpb.2024.114447. Epub 2024 Aug 8. Eur J Pharm Biopharm. 2024. PMID: 39122051 Free article.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
84 results